All News

Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, addresses how pharmacists can respond to questions patients may ask them about ketamine and other psychedelic treatments.

Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, explains how ketamine infusions work when administered in patients’ homes and what safety precautions would be taken by providers in this setting.

A variety of drugs from several medication classes are under investigation.

New composite pharmacy adherence measure is a major step in developing standard pharmacy performance measures focused on improving patient care.

Increasing physical activities and reducing caloric intake isn’t always enough to conquer obesity.

Many faculty members are adept at training and teaching pharmacists and pharmacy technicians how to perform physical exams and tests.

Taking appropriate doses of vitamins and minerals may aid in lowering the risk of cardiovascular disease.

Study shows that treatment with rituximab (Rituxan) for B-cell non-Hodgkin lymphoma prior to COVID-19 vaccination significantly lowered the number of patients who developed blocking antibodies for the virus.

Lack of immediate results, cultural barriers, and high costs lead many to gamble with their cardiovascular health, study results show.

An emerging focus is aligning targeted, safe, and effective therapies with patient goals.

Tralokinumab-ldrm is an interleukin-13 antagonist recently approved for the treatment of moderate-to-severe atopic dermatitis.

Ixazomib (Ninlaro, Takeda) has been found to improve survival in patients with multiple myeloma who have not undergone autologous stem cell transplant.

Sagely Naturals Pain Relief Cream combines CBD with powerful botanicals, peppermint, and menthol.

Diroximel fumarate (Vumerity) is indicated for the treatment of relapsing forms of multiple sclerosis.

Pharmacists are taking advantage of new opportunities, but there remain many other opportunities yet to be seized.

The calculation instrument displayed good discrimination, with a C-index of 0.72, as well as good calibration, investigators say.

Data suggest that omicron-specific CD8-positive T cell responses were more than 80% cross-reactive with the CD8-positive T cell response to the original strain of the virus.

New study results show that rapidly adding pounds in the first and final months of gestation likely plays a key role in the development of excess fat tissue in female children and adolescents.

Larotrectinib was the first drug to receive accelerated FDA approval for patients of all ages based on a common molecular marker, independent of tissue origin for targeted therapy.

Applying these findings in practice could improve clinicians’ ability to offer truly personalized cancer therapy by enabling consideration of toxicity along with other data predicting patients’ responses.

A product containing phosphoric acid as well as alcohol successfully neutralized all of the virus particles.

Fecal microbiota transplantation produces cure rates of 82%-88% in patients with recurrent clostridium difficile infections.

Selinexor demonstrated a 37% increase in probability that patients treated with the drug will be in remission at 12 months.

The use of a unique trimer to produce tier-2 neutralizing antibodies may help fight HIV.

Vazalore has been shown to cause fewer stomach-related adverse effects than traditional aspirin.

Pain from golfer's elbow may spread into the forearm and wrist.

Sutimlimab-jome is the only approved treatment for individuals with CAD and works by inhibiting the destruction of red blood cells.

The uncommon disease shares features of both lymphoma and myeloma.

The majority of study participants demonstrated improvement of infraorbital hollows through 1 year.

The agency has also approved the baclofen oral suspension for Azurity Pharmaceuticals to treat individuals with other spinal cord diseases or injuries.